StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report released on Monday morning. The brokerage issued a hold rating on the software maker’s stock.
A number of other brokerages have also weighed in on MDRX. TD Cowen cut their price objective on Veradigm from $26.00 to $15.00 and set a buy rating on the stock in a report on Tuesday, May 28th. Deutsche Bank Aktiengesellschaft reissued a hold rating and issued a $10.00 price objective (down from $15.00) on shares of Veradigm in a report on Tuesday, March 19th. Five research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, Veradigm has a consensus rating of Hold and an average target price of $12.00.
Read Our Latest Research Report on Veradigm
Veradigm Price Performance
Institutional Trading of Veradigm
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Tyro Capital Management LLC acquired a new stake in Veradigm during the first quarter worth about $9,055,000. Horrell Capital Management Inc. acquired a new stake in Veradigm during the first quarter worth about $385,000. Meadow Creek Wealth Advisors LLC acquired a new stake in Veradigm during the first quarter worth about $83,000. Vanguard Group Inc. boosted its position in Veradigm by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after purchasing an additional 95,291 shares in the last quarter. Finally, Wellington Management Group LLP boosted its position in Veradigm by 117.8% during the fourth quarter. Wellington Management Group LLP now owns 5,806,297 shares of the software maker’s stock worth $60,908,000 after purchasing an additional 3,140,483 shares in the last quarter.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- Are Penny Stocks a Good Fit for Your Portfolio?
- Autodesk’s Quarterly Results Could Drive It Back to Recent Highs
- What Are Dividend Contenders? Investing in Dividend Contenders
- A Bubble is Brewing in Oracle Stock, and it’s Only Getting Bigger
- EV Stocks and How to Profit from Them
- Danaos Benefits from Increasing Demand in Container Shipping
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.